ANIK – anika therapeutics inc. (US:NASDAQ)

News

Anika Therapeutics, Inc. (NASDAQ: ANIK) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.
Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics
Anika Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com